BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Eisai Inc. 

100 Tice Boulevard

Woodcliff Lake  New Jersey  07677  U.S.A.
Phone: 201-692-1100 Fax: 201-692-1804


SEARCH JOBS

View Clinical Trials from BioPharm Insight

Headquartered in Woodcliff Lake, New Jersey, Eisai Inc. was established in 1995 and is ranked among the top-20 U.S. pharmaceutical companies (based on retail sales). The company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business. Eisai’s areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

Eisai has a global product creation organization that includes U.S.-based R&D facilities in Maryland, Massachusetts, New Jersey, North Carolina and Pennsylvania as well as manufacturing facilities in Maryland and North Carolina. The company’s areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs. For more information about Eisai, please visit www.eisai.com.

For more information about Eisai, please visit www.eisai.com


 Key Statistics


Email:
Ownership: Subsidiary

Web Site: Eisai Inc.
Employees: Approximately 2,600
Symbol: ESALF.PK
 



Industry
Pharmaceutical






 Company News
Eisai Inc. (ESALF.PK) Presents New Data On Perampanel And Rufinamide At The 68th Annual American Epilepsy Society Meeting 12/8/2014 9:06:06 AM
Eisai Inc. (ESALF.PK) Release: New Research On Eribulin Mesylate And Netupitant/Palonosetron To Be Presented At Annual San Antonio Breast Cancer Symposium 12/2/2014 11:01:36 AM
Eisai Inc. (ESALF.PK) Doubles Down On U.K. Packaging Plant With £8 Million Investment; Boost Employment By 10% 11/26/2014 5:44:17 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Report Results Of An Investigational Phase 2 Trial Of Lorcaserin Hcl As An Aid For Smoking Cessation 11/3/2014 7:50:28 AM
Eisai Inc. (ESALF.PK) Release: Lorcaserin Data To Be Presented At The Obesity Society's Annual Scientific Meeting 10/31/2014 8:26:42 AM
Eisai Inc. (ESALF.PK) Launches "Search For The Next Medikidz Star" Contest For Kids Living With Epilepsy 10/24/2014 8:50:23 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Presentation Of Lorcaserin Hcl Data At The American College Of Clinical Pharmacy Annual Meeting 10/13/2014 7:38:28 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Publication Of Pooled Phase 3 Clinical Trial Analysis Of BELVIQ® (Lorcaserin Hcl) CIV In Postgraduate Medicine 10/10/2014 9:52:26 AM
Eisai Inc. (ESALF.PK) Release: Lorcaserin HCl Data To Be Presented At The American Society of Bariatric Physicians' 64th Annual Obesity & Associated Conditions Symposium 9/10/2014 8:46:59 AM
Eisai Inc. (ESALF.PK) Sells U.S. Rights To Zonegran® (zonisamide) Capsules To Concordia Pharmaceuticals 9/3/2014 11:40:18 AM
12345678910...